Jafron Biomedical Co.,Ltd.
SZSE:300529.SZ
20.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 425.723 | 880.918 | 1,195.841 | 872.996 | 568.693 | 400.945 | 284.452 | 202.118 | 200.441 | 160.048 | 126.785 | 100.024 | 75.762 |
| Depreciation & Amortization
| 94.793 | 73.995 | 54.06 | 36.727 | 29.789 | 21.793 | 16.198 | 14.618 | 9.265 | 3.592 | 2.46 | 2.476 | 1.925 |
| Deferred Income Tax
| -1.014 | -2 | -17.226 | -2.903 | -2.931 | -2.933 | -0.703 | -0.276 | -0.339 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 19.097 | -8.735 | 7.518 | 22.351 | 17.127 | 11.312 | 5.019 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 291.054 | -101.987 | -0.302 | 35.998 | -1.752 | -13.519 | 28.377 | -40.792 | -5.969 | -28.788 | 2.939 | 16.833 | -0.453 |
| Accounts Receivables
| 277.225 | -7.902 | -110.412 | -83.405 | -34.226 | -39.519 | -31.743 | -26.021 | -24.604 | -24.38 | -10.547 | 1.499 | 0 |
| Inventory
| -37.299 | -152.743 | -75.931 | -28.288 | -31.204 | -15.87 | 4.383 | -10.921 | -4.729 | -8.31 | -0.186 | -5.896 | -4.286 |
| Accounts Payables
| 52.142 | 60.658 | 203.267 | 150.595 | 66.61 | 44.804 | 56.44 | -3.574 | 23.704 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 19.097 | -2 | -17.226 | -2.903 | -2.931 | 2.351 | 23.994 | -29.871 | -1.24 | -20.478 | 3.125 | 22.729 | 3.834 |
| Other Non Cash Items
| 72.523 | 41.608 | 9.525 | -7.681 | -27.431 | -25.142 | -24.932 | 2.691 | 1.441 | 2.502 | 1.142 | 0.916 | -0.173 |
| Operating Cash Flow
| 916.744 | 883.8 | 1,249.415 | 957.489 | 583.495 | 384.077 | 304.096 | 178.635 | 205.178 | 137.354 | 133.326 | 120.25 | 77.062 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -247.253 | -475.887 | -537.412 | -357.114 | -220.671 | -173.527 | -177.729 | -28.655 | -61.403 | -64.29 | -63.143 | -53.426 | -14.58 |
| Acquisitions Net
| 12.604 | 6.906 | 0.987 | 357.928 | -6.277 | -28.88 | -12.101 | 28.831 | -0.5 | -0.897 | -1.674 | 0 | 0 |
| Purchases Of Investments
| -15 | -2,050 | -4,553.5 | -1,310 | -2,842.793 | -3,616.2 | -2,290 | -300 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 2,213.264 | 4,419.705 | 1,325.194 | 2,872.597 | 3,563.678 | 2,420.425 | 202.039 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -2.396 | -0.184 | 0 | -357.114 | 0.019 | 0 | 0.07 | -28.655 | 0.001 | 0.064 | 3.828 | 1.178 | -4.996 |
| Investing Cash Flow
| -249.649 | -305.901 | -670.22 | -341.106 | -197.125 | -254.928 | -59.335 | -126.441 | -61.901 | -65.123 | -60.989 | -52.248 | -19.576 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -418.42 | -296.316 | -998.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | -291.124 | -498.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -382.583 | -5.192 | -500.127 | -8.286 | -5.341 | -8.968 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -535.24 | -716.985 | -531.016 | -377.809 | -251.01 | -146.155 | -83.321 | 0 | -88.8 | -87.75 | -37.5 | -24.75 | -5.61 |
| Other Financing Activities
| -308.546 | 956.119 | 2,692.795 | 73.068 | 60.909 | 31.646 | 139.635 | 420.562 | 0 | 0 | 0 | 0 | 18.987 |
| Financing Cash Flow
| -451.911 | -365.934 | 165.175 | -313.028 | -195.442 | -114.509 | 56.314 | 420.562 | -88.8 | -87.75 | -37.5 | -24.75 | 13.377 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0.011 | -0.036 | -0 | -0.036 | -0.001 | 0.004 | 0 | 0 | 0 | 0 | -0 | -0 | -0 |
| Net Change In Cash
| 215.195 | 211.929 | 744.37 | 303.32 | 190.928 | 14.644 | 301.075 | 472.756 | 54.477 | -15.519 | 34.837 | 43.251 | 70.863 |
| Cash At End Of Period
| 2,741.543 | 2,526.349 | 2,314.42 | 1,570.05 | 1,266.73 | 1,075.802 | 1,061.159 | 760.084 | 287.327 | 232.85 | 248.369 | 213.533 | 170.282 |